MMP1 Gene Epidermolysis bullosa dystrophica autosomal recessive modifier of Genetic Test
Test Name: MMP1 Gene Epidermolysis bullosa dystrophica autosomal recessive modifier of Genetic Test
Components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test type: Osteology Dermatology Immunology Disorders
- Doctor: Dermatologist
- Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for MMP1 Gene Epidermolysis bullosa dystrophica, autosomal recessive, modifier of NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MMP1 Gene Epidermolysis bullosa dystrophica, autosomal recessive, modifier of NGS Genetic DNA Test gene MMP1.
Test Details:
The MMP1 gene is not directly associated with Epidermolysis bullosa dystrophica, which is a genetic disorder characterized by skin blistering and fragility. However, it is possible that the MMP1 gene may act as a modifier of the disease. Modifier genes are genes that can influence the severity or progression of a particular genetic disorder when present alongside the primary disease-causing gene mutation. In the case of Epidermolysis bullosa dystrophica, the primary gene mutations are typically found in the COL7A1 gene.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or the entire genome. It can help identify mutations in the primary disease-causing gene as well as potential modifier genes like MMP1. By analyzing the MMP1 gene alongside the primary disease-causing gene, NGS genetic testing may provide a more comprehensive understanding of the genetic factors contributing to the development and progression of Epidermolysis bullosa dystrophica. This information can be valuable for prognosis, treatment planning, and genetic counseling.
Test Name | MMP1 Gene Epidermolysis bullosa dystrophica autosomal recessive modifier of Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MMP1 Gene Epidermolysis bullosa dystrophica, autosomal recessive, modifier of NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MMP1 Gene Epidermolysis bullosa dystrophica, autosomal recessive, modifier of NGS Genetic DNA Test gene MMP1 |
Test Details |
The MMP1 gene is not directly associated with Epidermolysis bullosa dystrophica, which is a genetic disorder characterized by skin blistering and fragility. However, it is possible that the MMP1 gene may act as a modifier of the disease. Modifier genes are genes that can influence the severity or progression of a particular genetic disorder when present alongside the primary disease-causing gene mutation. In the case of Epidermolysis bullosa dystrophica, the primary gene mutations are typically found in the COL7A1 gene. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or the entire genome. It can help identify mutations in the primary disease-causing gene as well as potential modifier genes like MMP1. By analyzing the MMP1 gene alongside the primary disease-causing gene, NGS genetic testing may provide a more comprehensive understanding of the genetic factors contributing to the development and progression of Epidermolysis bullosa dystrophica. This information can be valuable for prognosis, treatment planning, and genetic counseling. |